公开(公告)号：US20160361562A1

公开(公告)日：2016-12-15

申请号：US15234299

申请日：2016-08-11

Applicant: St. Jude Medical, Atrial Fibrillation Division, Inc.

Inventor： Karin Järverud ,  Cecilia Emanuelsson ,  Anders Björling ,  Kjell Noren

IPC: A61N5/06 ,  A61N1/05 ,  A61B18/20 ,  A61B5/0408

CPC classification number: A61N5/0613 ,  A61B5/0408 ,  A61B5/05 ,  A61B5/103 ,  A61B18/18 ,  A61B18/20 ,  A61B2018/00577 ,  A61N1/00 ,  A61N1/056 ,  A61N1/30 ,  A61N1/362 ,  A61N1/39 ,  A61N5/06 ,  A61N5/0603 ,  A61N2005/0602 ,  A61N2005/0609 ,  A61N2005/0612 ,  A61N2005/0626 ,  A61N2005/063 ,  A61N2005/0659 ,  A61N2005/0662

Abstract: In response to local or systemic inflammation in a patient, photobiomodulation therapy is applied to a cardiac location to reduce the risk and/or occurrence of cardiac arrhythmia. Once inflammation is identified, photobiomodulation therapy can be applied in any suitable fashion (e.g., via a catheter- or transesophageal probe-mounted photoemitter, via an externally-applied photoemitter, or via photoemitter incorporated into an implantable medical device). Photobiomodulation therapy can also be employed to good advantage in conjunction with non-photobiomodulation therapy (e.g., traditional cardiac rhythm management therapies).

Abstract translation: 响应于患者的局部或全身炎症，将光生物调节治疗应用于心脏位置以降低心律失常的风险和/或发生。 一旦发现炎症，可以以任何合适的方式（例如经由经导管或经食管探针安装的光发射器，经由外部施加的光电探测器，或通过并入可植入医疗装置中的光电发生器）应用光生物调节治疗。 结合非光生物调节治疗（例如传统的心律管理疗法）也可以利用光生物调节治疗来获得良好的优点。